(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

D DEMENTIA DISCOVERY FUND

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

D DEMENTIA DISCOVERY FUND

ST13

US500000079308667

Classe

5, 36, 42, 44

Pedido

79308667

Registro

6703551

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

21/03/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 36, 42, 44

Data de depósito

09/09/2019

Data de registro

19/04/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/04/2022

Última transação

21/03/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

21

Localização do titular

GB

Examinador

DIBLE, JONATHON I

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the dark blue stylized wording "DEMENTIA" above the light blue stylized wording "DISCOVERY" above the green stylized wording "FUND", all to the right of a stylized letter "D" represented by multiple shaded dots colored in various shades of green, light blue, dark blue, and purple and connected by gray lines arranged to form triangular outlines. The color white appearing in the mark represents background and is not claimed as a feature of the mark.

Titulares e representantes

Titulares

S. L. (pessoa física)

Representantes

Syed Abedi Seed IP Law Group LLP

Classificação técnica

Classes Nice

Classe 5Classe 36Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical and medical preparations and substances for the treatment of dementia; Pharmaceutical and medical preparations and substances for use in the treatment and prevention of dementia; Sanitary preparations for medical purposes; Pharmaceutical preparationsall for use in the treatment and prevention of brain diseases and degenerative dementia disorders; Antiseptic preparations; Prescription pharmaceuticals for humans as well as other pharmaceutical products for the treatment of dementia; Dietetic foods adapted for medical usedietary and health food supplements; Vitamins; Dietetic substances adapted for medical usefood for babiesteensadultselders; Homeopathic preparations and substances for the treatment of dementia; Medicated drinks; Anti-diabetic drugs; Hypertension medications; Steroid hormones; Non-steroidal anti-inflammatory drugs

Classe 36

Insurance agency and brokerage; Financial affairs and monetary affairsfinancial informationmanagementanalysis services; Real estate agency services; Financial servicesfinancing the medical research of others; Arranging of financing for humanitarian aid and developmentincluding charitable fundraising and support services for research in dementia; Charitable fundraising regarding funding for dementia research; Charitable servicesproviding financial assistance to disadvantaged persons for foodclothinghealth care; Financial sponsorship services of charitable musical entertainmentrunning and walkingfood tastingdinner and dance events; Financial servicesmanaging and monitoring of charitable funds supporting dementia research; Accepting and administering monetary charitable contributionsdistribution and allocation of charitable funds; Providing of information in the field of charitable monetary giving through corporate donations and payroll donations by employees; Informationadvisoryconsultancy services in relation to the aforesaid services

Classe 42

Scientific and technological servicesresearch and design in the field of goods and services connected with dementia treatment; Scientific and technological servicesresearch and design in the field of goods and services connected with dementia; Industrial analysis and research services in the field of goods and services connected with dementia treatment to assure compliance with industry standards; Design and development of computer hardware and software; Design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of goods and services connected with dementia treatment; Laboratory research in the field of goods and services connected with dementia treatment; Laboratory research services in the field of goods and services connected with dementia treatment; Scientific and technological serviceslaboratory testing services in the field of goods and services connected with dementia treatment; Medical laboratory services; Medical and scientific research services in relation to the causessymptomsdiagnosistreatment and prevention of dementia; Genetic research concerning dementia; Provision of medical and scientific research facilities; Medical and scientific research laboratories; Medical and scientific research in relation to medicines and pharmaceuticals; Medical research services; Design and development of software in the field of mobile device applications; Design and development of computer programmes

Classe 44

Medical services; The provision of informationonline via the Interneton the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; Medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; Medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; Medical services concerning dementiaphysiciannursingmidwiferyhospital services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Hygienic and beauty care for human beings; Agricultural advice services; Dentistry services; Medical analysis for the diagnosis and treatment of individuals and groups of people with dementia related to x-ray examinations and taking blood samples; Pharmaceutical advice; Medical clinic services; Medical treatment services; Medical analysis services; Nursing services; Informationadvisoryconsultancy services relating to all the aforesaid

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

17/03/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/03/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

17/03/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/03/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/03/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/10/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

26/09/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/09/2022

FIMP

FINAL DISPOSITION PROCESSED

01/09/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

19/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

19/04/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/02/2022

PUBO

PUBLISHED FOR OPPOSITION

01/02/2022

GPNX

NOTIFICATION PROCESSED BY IB

29/01/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/01/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2022

ALIE

ASSIGNED TO LIE

29/12/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/12/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

22/12/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/12/2021

GNFR

FINAL REFUSAL E-MAILED

03/12/2021

CNFR

FINAL REFUSAL WRITTEN

03/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/10/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/10/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/10/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

26/06/2021

RFNT

REFUSAL PROCESSED BY IB

31/05/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/05/2021

RFRR

REFUSAL PROCESSED BY MPU

03/05/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

29/04/2021

CNRT

NON-FINAL ACTION WRITTEN

28/04/2021

MAFR

APPLICATION FILING RECEIPT MAILED

20/04/2021

DOCK

ASSIGNED TO EXAMINER

16/04/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/04/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

15/04/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace D DEMENTIA DISCOVERY FUND ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.